On-demand l-thyroxine replacement therapy in post-lobectomy papillary thyroid cancer: a prospective nonrandomized controlled study
On-demand l -thyroxine replacement therapy benefit three-fourths of post-lobectomy low- to intermediate-risk PTC patients avoid l -thyroxine supplementation, while preserving equivalent short-term treatment response and RFS.
Authors
- Ruiying Liu (ORCID: https://orcid.org/0000-0002-4952-8602)
- Lida Liao
- Haixia Guan (ORCID: https://orcid.org/0000-0003-3155-2847)
- Zongmin Zhang (ORCID: https://orcid.org/0000-0002-6409-4603)
- Chengwei Xing
- Kai You Wang (ORCID: https://orcid.org/0000-0002-6170-4744)
- Jie Liu (ORCID: https://orcid.org/0000-0003-3975-7978)
- Siyuan Xu (ORCID: https://orcid.org/0000-0003-4928-9434)
- Keyao Xian
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1097/js9.0000000000003905
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00